Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii.

Yarovinsky F, Andersen JF, King LR, Caspar P, Aliberti J, Golding H, Sher A.

J Biol Chem. 2004 Dec 17;279(51):53635-42. Epub 2004 Oct 6.

2.

CCR5 N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18.

Golding H, Khurana S, Yarovinsky F, King LR, Abdoulaeva G, Antonsson L, Owman C, Platt EJ, Kabat D, Andersen JF, Sher A.

J Biol Chem. 2005 Aug 19;280(33):29570-7. Epub 2005 Jun 23.

3.

Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii.

Golding H, Aliberti J, King LR, Manischewitz J, Andersen J, Valenzuela J, Landau NR, Sher A.

Blood. 2003 Nov 1;102(9):3280-6. Epub 2003 Jul 10.

4.

Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.

Chelli M, Alizon M.

J Biol Chem. 2001 Dec 14;276(50):46975-82. Epub 2001 Oct 12.

6.

Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function.

Howard OM, Shirakawa AK, Turpin JA, Maynard A, Tobin GJ, Carrington M, Oppenheim JJ, Dean M.

J Biol Chem. 1999 Jun 4;274(23):16228-34.

7.

Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.

Blanpain C, Lee B, Vakili J, Doranz BJ, Govaerts C, Migeotte I, Sharron M, Dupriez V, Vassart G, Doms RW, Parmentier M.

J Biol Chem. 1999 Jul 2;274(27):18902-8.

9.

Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 loop library.

Yusa K, Maeda Y, Fujioka A, Monde K, Harada S.

J Biol Chem. 2005 Aug 26;280(34):30083-90. Epub 2005 Jun 27.

10.

Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES.

Nardese V, Longhi R, Polo S, Sironi F, Arcelloni C, Paroni R, DeSantis C, Sarmientos P, Rizzi M, Bolognesi M, Pavone V, Lusso P.

Nat Struct Biol. 2001 Jul;8(7):611-5.

PMID:
11427892
11.

Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.

Owais M, Arya SK.

J Hum Virol. 1999 Sep-Oct;2(5):270-82.

PMID:
10551733
12.

Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells.

Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reis e Sousa C, Fairlamb A, Ribeiro JM, Sher A.

Nat Immunol. 2003 May;4(5):485-90. Epub 2003 Mar 31.

PMID:
12665855
13.
14.

Overexpression, purification and assessment of cyclosporin binding of a family of cyclophilins and cyclophilin-like proteins of the human malarial parasite Plasmodium falciparum.

Marín-Menéndez A, Bell A.

Protein Expr Purif. 2011 Aug;78(2):225-34. doi: 10.1016/j.pep.2011.04.012. Epub 2011 Apr 29.

PMID:
21549842
15.

Identification of an interleukin-15alpha receptor-binding site on human interleukin-15.

Bernard J, Harb C, Mortier E, Quéméner A, Meloen RH, Vermot-Desroches C, Wijdeness J, van Dijken P, Grötzinger J, Slootstra JW, Plet A, Jacques Y.

J Biol Chem. 2004 Jun 4;279(23):24313-22. Epub 2004 Mar 23.

16.

Interaction of small molecule inhibitors of HIV-1 entry with CCR5.

Seibert C, Ying W, Gavrilov S, Tsamis F, Kuhmann SE, Palani A, Tagat JR, Clader JW, McCombie SW, Baroudy BM, Smith SO, Dragic T, Moore JP, Sakmar TP.

Virology. 2006 May 25;349(1):41-54. Epub 2006 Feb 21.

17.

Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes.

Carpentier M, Allain F, Haendler B, Denys A, Mariller C, Benaïssa M, Spik G.

J Biol Chem. 1999 Apr 16;274(16):10990-8.

18.

Structural basis for the interaction of CCR5 with a small molecule, functionally selective CCR5 agonist.

Saita Y, Kodama E, Orita M, Kondo M, Miyazaki T, Sudo K, Kajiwara K, Matsuoka M, Shimizu Y.

J Immunol. 2006 Sep 1;177(5):3116-22.

19.

Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor.

Chelli M, Alizon M.

J Biol Chem. 2002 Oct 18;277(42):39388-96. Epub 2002 Aug 1.

20.

Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1.

Seet BT, Barrett J, Robichaud J, Shilton B, Singh R, McFadden G.

J Biol Chem. 2001 Aug 10;276(32):30504-13. Epub 2001 May 21.

Supplemental Content

Support Center